Epigenetic therapies to concurrently target DIPG tumor cells and harness the immune system |
The Regents of the University of Michigan / Sriram Venneti, MD/PhD |
R Accelerated Award Grants |
2022 |
Michigan |
Targeting Kinase Inhibitor Induced DNA-Damage Response in Ph-Like ALL |
Temple University / Christian Hurtz, PhD |
'A' Award Grants |
2022 |
Pennsylvania |
Characterizing the Developmental Context of Pediatric Leukemia
|
Icahn School of Medicine at Mount Sinai / Elvin Wagenblast, PhD |
'A' Award Grants |
2022 |
New York |
Phase I trial of multilamellar mRNA lipid particles for recurrent pediatric high grade glioma |
University of Florida / Elias Sayour, MD/PhD |
R Accelerated Award Grants |
2022 |
Florida |
STING Pathway Activation: The Missing Link between Genomic Instability and Antitumor Immunity in Osteosarcoma |
University of California San Francisco / Elizabeth Young, MD |
Young Investigator Grants |
2021 |
California |
Activating Metabolic Pathways to Increase the Persistence of Leukemia Targeting T Cells |
Children's Hospital of Pittsburgh / Erica Braverman, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies |
Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD |
Young Investigator Grants |
2021 |
Ohio |
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children's Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Dissecting Functional uORFs as a Source of Cancer Genes in High-Risk Medulloblastoma |
Dana-Farber Cancer Institute / John Prensner, MD/PhD |
Young Investigator Grants |
2021 |
Massachusetts |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |